A recent article published in Value in Health proposes a “tailored checklist” for analysts and decision makers when conducting economic evaluations of gene therapies.
“The aim of this article was to provide a more detailed analysis of the characteristics of gene therapy and the extent to which these characteristics warrant modifications to the methods suggested in general reference cases for economic evaluation,” the study’s authors write.
To read the article, click here. (Subscription required)
